Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2073490rdf:typepubmed:Citationlld:pubmed
pubmed-article:2073490lifeskim:mentionsumls-concept:C0072115lld:lifeskim
pubmed-article:2073490lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:2073490lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2073490lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:2073490pubmed:issue5lld:pubmed
pubmed-article:2073490pubmed:dateCreated1991-4-17lld:pubmed
pubmed-article:2073490pubmed:abstractTextCrude enzyme solutions of prolidase were extracted from cultured human skin fibroblasts derived from control and prolidase-deficient sisters. Two forms of prolidases (prolidase-I and II) were partially purified by high performance liquid chromatography equipped with an ion exchange column. On gel filtration, the relative molecular weights of prolidase-I and II were estimated to be MW = 105,000 and 151,000, respectively. The substrate specificity of partially purified prolidase-I and II in control fibroblasts was estimated against Gly-Pro, Ala-Pro, Met-Pro. Each form of prolidase differed in its substrate specificity. In prolidase-deficient sisters, the elder with typical clinical manifestations and the younger with only slight clinical manifestations, the activity of prolidase-I was absent. However, the activity of prolidase-II was sufficiently present in both sisters. The substrate specificity of prolidase-II in the patients was similar to that of control. No difference in substrate specificity was found between these two patients.lld:pubmed
pubmed-article:2073490pubmed:languageenglld:pubmed
pubmed-article:2073490pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2073490pubmed:citationSubsetIMlld:pubmed
pubmed-article:2073490pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2073490pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2073490pubmed:statusMEDLINElld:pubmed
pubmed-article:2073490pubmed:monthSeplld:pubmed
pubmed-article:2073490pubmed:issn0923-1811lld:pubmed
pubmed-article:2073490pubmed:authorpubmed-author:KodamaHHlld:pubmed
pubmed-article:2073490pubmed:authorpubmed-author:OhhashiTTlld:pubmed
pubmed-article:2073490pubmed:authorpubmed-author:OonoTTlld:pubmed
pubmed-article:2073490pubmed:authorpubmed-author:ArataJJlld:pubmed
pubmed-article:2073490pubmed:authorpubmed-author:YasutomiHHlld:pubmed
pubmed-article:2073490pubmed:issnTypePrintlld:pubmed
pubmed-article:2073490pubmed:volume1lld:pubmed
pubmed-article:2073490pubmed:ownerNLMlld:pubmed
pubmed-article:2073490pubmed:authorsCompleteYlld:pubmed
pubmed-article:2073490pubmed:pagination319-23lld:pubmed
pubmed-article:2073490pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:meshHeadingpubmed-meshheading:2073490-...lld:pubmed
pubmed-article:2073490pubmed:year1990lld:pubmed
pubmed-article:2073490pubmed:articleTitleCharacterization of fibroblast-derived prolidase. The presence of two forms of prolidase.lld:pubmed
pubmed-article:2073490pubmed:affiliationDepartment of Dermatology, Okayama University Medical School, Japan.lld:pubmed
pubmed-article:2073490pubmed:publicationTypeJournal Articlelld:pubmed